Lee W Jones Selected Research

Insulin Resistance

2/2020	Randomized Phase II Trial of Exercise, Metformin, or Both on Metabolic Biomarkers in Colorectal and Breast Cancer Survivors.
12/2013	Immunological and hormonal effects of exercise: implications for cancer cachexia.
9/2013	Effects of a 12-week home-based exercise program on the level of physical activity, insulin, and cytokines in colorectal cancer survivors: a pilot study.
8/2003	Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lee W Jones Research Topics

Disease

65	Neoplasms (Cancer) 04/2022 - 05/2003
47	Breast Neoplasms (Breast Cancer) 05/2024 - 05/2003
11	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 05/2003
10	Fatigue 10/2023 - 05/2003
10	Cardiotoxicity 01/2020 - 01/2011
8	Lung Neoplasms (Lung Cancer) 12/2021 - 03/2009
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 08/2012
6	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 05/2013
4	Obesity 01/2022 - 08/2014
4	Inflammation (Inflammations) 12/2020 - 04/2009
4	Weight Loss (Weight Reduction) 02/2020 - 08/2014
4	Insulin Resistance 02/2020 - 08/2003
4	Neoplasm Metastasis (Metastasis) 01/2017 - 02/2010
3	Chronic Disease (Chronic Diseases) 10/2023 - 12/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 11/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2014 - 02/2007
3	Hypoxia (Hypoxemia) 09/2013 - 02/2010
3	Brain Neoplasms (Brain Tumor) 11/2010 - 05/2006
2	Pathologic Complete Response 01/2022 - 01/2017
2	Body Weight (Weight, Body) 01/2022 - 03/2007
2	Weight Gain 01/2019 - 08/2015
2	Sarcopenia 01/2019 - 01/2016
2	Hypertension (High Blood Pressure) 01/2019 - 01/2016
2	Lymphoma (Lymphomas) 12/2016 - 05/2005
2	Left Ventricular Dysfunction 07/2013 - 08/2009
2	Dyspnea (Shortness of Breath) 06/2012 - 03/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 06/2012 - 03/2009
2	Glioblastoma (Glioblastoma Multiforme) 04/2011 - 08/2009
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 12/2020
1	Bicuspid Aortic Valve Disease 01/2020
1	Aortic Dissection 01/2020
1	Thoracic Aortic Aneurysm 01/2020
1	Heart Diseases (Heart Disease) 03/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 12/2020 - 08/2003
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 09/2005
6	Clostridium perfringens epsilon-toxinIBA 10/2023 - 02/2007
6	Trastuzumab (Herceptin)FDA Link 01/2020 - 05/2007
6	AnthracyclinesIBA 01/2020 - 05/2007
5	AndrogensIBA 11/2023 - 05/2003
5	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 08/2003
5	Insulin (Novolin)FDA Link 11/2017 - 08/2003
4	C-Reactive ProteinIBA 12/2020 - 09/2005
3	Oxygen (Dioxygen)IBA 10/2023 - 06/2009
3	LeptinIBA 02/2020 - 01/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 09/2013
2	Metformin (Glucophage)FDA LinkGeneric 12/2020 - 02/2020
2	Interleukin-6 (Interleukin 6)IBA 12/2020 - 01/2016
2	Cytotoxins (Cytolysins)IBA 01/2020 - 04/2011
2	AdipokinesIBA 11/2017 - 09/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 04/2016
2	pertuzumabIBA 01/2017 - 04/2016
2	taxaneIBA 04/2016 - 05/2007
2	AdiponectinIBA 01/2016 - 09/2013
2	CholesterolIBA 05/2015 - 08/2012
2	beta-Aminoethyl Isothiourea (AET)IBA 01/2014 - 09/2013
2	CytokinesIBA 09/2013 - 09/2013
2	Insulin-Like PeptidesIBA 09/2013 - 08/2003
2	Insulin-Like Growth Factor Binding ProteinsIBA 09/2013 - 08/2003
2	Insulin-Like Growth Factor I (IGF-1)IBA 09/2013 - 08/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2012 - 04/2011
2	Complement System Proteins (Complement)IBA 06/2012 - 05/2006
2	Hormones (Hormone)IBA 10/2007 - 05/2003
1	enzalutamideIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020
1	Cytidine Monophosphate (CMP)IBA 11/2019
1	SolutionsIBA 01/2019
1	Phosphocreatine (Neoton)IBA 01/2018
1	CarbonIBA 01/2018
1	Cardiac GlycosidesIBA 11/2017
1	salicylhydroxamic acid (SHAM)IBA 11/2017
1	Digoxin (Digitek)FDA LinkGeneric 11/2017
1	ClaudinsIBA 11/2017
1	CarcinogensIBA 01/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2016
1	Troponin IIBA 04/2016

Therapy/Procedure

67	Therapeutics 11/2023 - 05/2003
22	Drug Therapy (Chemotherapy) 05/2024 - 05/2003
18	Exercise Therapy (Therapy, Exercise) 12/2023 - 06/2009
8	Adjuvant Chemotherapy 12/2023 - 09/2005
5	Radiotherapy 10/2023 - 05/2003
4	Neoadjuvant Therapy 01/2022 - 09/2013
4	Resistance Training 12/2021 - 04/2010
4	Cell Transplantation 01/2019 - 11/2015
3	Aftercare (After-Treatment) 11/2020 - 01/2016
3	Thoracotomy 06/2014 - 05/2013
2	Immunotherapy 01/2020 - 01/2019
2	Cardiac Rehabilitation 01/2020 - 01/2019
2	Caloric Restriction 01/2020 - 01/2016
2	Stem Cell Transplantation 12/2016 - 02/2015
2	Hematopoietic Stem Cell Transplantation 02/2016 - 02/2015
2	Prostatectomy (Retropubic Prostatectomy) 01/2015 - 05/2014
2	Complementary Therapies (Alternative Medicine) 05/2013 - 12/2006
1	Wearable Electronic Devices 04/2022
1	Castration 01/2022
1	Patient Readmission 01/2020